Twin City Private Wealth LLC Acquires 1,189 Shares of Sanofi (NASDAQ:SNY)

Twin City Private Wealth LLC lifted its holdings in shares of Sanofi (NASDAQ:SNY) by 11.2% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 11,831 shares of the company’s stock after acquiring an additional 1,189 shares during the quarter. Twin City Private Wealth LLC’s holdings in Sanofi were worth $571,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently made changes to their positions in the business. LPL Financial LLC boosted its stake in Sanofi by 12.5% in the 4th quarter. LPL Financial LLC now owns 1,284,096 shares of the company’s stock valued at $61,932,000 after purchasing an additional 142,290 shares during the period. Guardian Partners Inc. bought a new stake in Sanofi in the 4th quarter valued at $9,162,000. Sei Investments Co. boosted its stake in Sanofi by 8.0% in the 4th quarter. Sei Investments Co. now owns 644,302 shares of the company’s stock valued at $31,075,000 after purchasing an additional 47,801 shares during the period. American Century Companies Inc. boosted its stake in Sanofi by 1.8% in the 4th quarter. American Century Companies Inc. now owns 1,707,057 shares of the company’s stock valued at $82,331,000 after purchasing an additional 29,536 shares during the period. Finally, Lee Danner & Bass Inc. bought a new stake in Sanofi in the 4th quarter valued at $31,000. 14.04% of the stock is currently owned by institutional investors.

Sanofi Price Performance

Shares of NASDAQ SNY opened at $56.90 on Monday. The stock has a market capitalization of $144.40 billion, a PE ratio of 22.85, a P/E/G ratio of 1.01 and a beta of 0.58. The company has a debt-to-equity ratio of 0.15, a current ratio of 1.46 and a quick ratio of 1.14. The business has a fifty day moving average price of $54.55 and a two-hundred day moving average price of $52.85. Sanofi has a fifty-two week low of $45.22 and a fifty-two week high of $60.12.

Sanofi (NASDAQ:SNY) last announced its quarterly earnings data on Thursday, January 30th. The company reported $0.70 earnings per share for the quarter, meeting the consensus estimate of $0.70. Sanofi had a return on equity of 25.61% and a net margin of 12.77%. As a group, equities analysts predict that Sanofi will post 4.36 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

Several analysts recently issued reports on SNY shares. Sanford C. Bernstein upgraded Sanofi to a “strong-buy” rating in a research note on Thursday, January 30th. Deutsche Bank Aktiengesellschaft upgraded Sanofi from a “sell” rating to a “hold” rating in a research note on Thursday, January 30th. The Goldman Sachs Group initiated coverage on Sanofi in a report on Friday. They issued a “neutral” rating and a $65.00 price objective for the company. Finally, StockNews.com cut Sanofi from a “buy” rating to a “hold” rating in a report on Thursday, December 12th. Three equities research analysts have rated the stock with a hold rating, one has issued a buy rating and two have given a strong buy rating to the stock. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $62.50.

About Sanofi

Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, Canada, and internationally. It operates through Pharmaceuticals, Vaccines, and Consumer Healthcare segments. The company provides specialty care, such as DUPIXENT, neurology and immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes and cardiovascular diseases; and established prescription products.